Successful treatment with hydrogen rich water in a case of chronic graft-versus-host-disease

被引:3
|
作者
Qian, Li-ren [1 ]
Shen, Jian-liang [1 ]
机构
[1] Navy Gen Hosp, Dept Hematol, Beijing, Peoples R China
来源
MEDICAL GAS RESEARCH | 2016年 / 6卷 / 03期
关键词
graft-versus-host disease; hydrogen; cytokines; transplantation|;
D O I
10.4103/2045-9912.191366
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The incidence of chronic graft-versus-host-disease is rising year by year, which has become the leading cause of non-transplantation related death and has become the most difficult complication of allogeneic hematopoietic stem cell transplantation to deal with. Inflammation and fibrosis play dominant roles in the pathogenesis of chronic graft-versus-host-disease. Studies have shown that molecular hydrogen has anti-inflammatory, antioxidant, anti-fibrosis effects. Therefore, we hypothesized that molecular hydrogen may have therapeutic effects on chronic graft-versus-host-disease. Here, we report a patient with severe chronic graft-versus-host-disease successfully treated by drinking hydrogen rich water which may be a safe and effective method for chronic graft-versus-host-disease.
引用
收藏
页码:177 / 179
页数:3
相关论文
共 50 条
  • [1] Pathogenesis of graft-versus-host-disease
    Sale, GE
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 21 - 23
  • [2] Cutaneous Graft-versus-Host-Disease
    Karrer, S
    HAUTARZT, 2003, 54 (05): : 465 - 480
  • [3] Novel strategies for the treatment and diagnosis of graft-versus-host-disease
    Ferrara, James L. M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) : 91 - 97
  • [4] Graft-versus-Host-Disease der Haut
    S. Karrer
    Der Hautarzt, 2003, 54 (5): : 465 - 482
  • [5] Use of Prescription Sialagogues for Management of Xerostomia in Chronic Graft-versus-Host-Disease
    Mousavian, Mohammad
    Sroussi, Herve
    Villa, Alessandro
    Cutler, Corey
    Treister, Nathaniel
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (06): : 480.e1 - 480.e5
  • [6] DIFFERENTIAL CYTOKINE EXPRESSION IN ACUTE AND CHRONIC MURINE GRAFT-VERSUS-HOST-DISEASE
    ALLEN, RD
    STALEY, TA
    SIDMAN, CL
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (02) : 333 - 337
  • [7] The use of topical cyclosporin A in ocular graft-versus-host-disease
    Kiang, E
    Tesavibul, N
    Yee, R
    Kellaway, J
    Przepiorka, D
    BONE MARROW TRANSPLANTATION, 1998, 22 (02) : 147 - 151
  • [8] Endoscopic Findings and Clinical Manifestation of Graft-Versus-Host-Disease
    Ayvaz, M. A.
    Allescher, H. D.
    ENDOSKOPIE HEUTE, 2012, 25 (01) : 30 - 35
  • [9] Prevalence and Risk Factors Associated With Corneal Perforation in Chronic Ocular Graft-Versus-Host-Disease
    Sinha, Shruti
    Singh, Rohan Bir
    Dohlman, Thomas H.
    Taketani, Yukako
    Yin, Jia
    Dana, Reza
    CORNEA, 2021, 40 (07) : 877 - 882
  • [10] Hydroxychloroquine for the treatment of chronic graft-versus-host disease
    Gilman, AL
    Chan, KW
    Mogul, M
    Morris, C
    Goldman, FD
    Boyer, M
    Cirenza, E
    Mazumder, A
    Gehan, E
    Cahill, R
    Frankel, S
    Schultz, K
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) : 327 - 334